Chemical Communications · 2011 · 42 citations · 25 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryDrug MetabolismMolecular PharmacologyCytochrome P450 EnzymesCytochrome P450 InteractionsCytochrome P450-mediated MetabolismDrug-metabolizing EnzymesHepatic Drug MetabolismBiological Activity FeaturesCyp450-mediated InteractionsCytochrome P450 Enzyme ActivityCytochrome P450 ModulationDose De-intensificationTissue-specific Dose Optimization
The identification of an agent that is selectively activated by a cytochrome P450 (CYP) has the potential for tissue specific dose intensification as a means of significantly improving its therapeutic value. Towards this goal, we disclose evidence for the pathway of activation of a duocarmycin analogue, ICT2700, which targets CYP1A1 for biological activity.
25